WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 50 filers reported holding WEREWOLF THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,470 | -62.3% | 6,750 | 0.0% | 0.01% | -64.7% |
| Q1 2024 | $43,740 | +67.9% | 6,750 | 0.0% | 0.02% | +54.5% |
| Q4 2023 | $26,055 | +224.7% | 6,750 | +80.0% | 0.01% | +175.0% |
| Q3 2023 | $8,025 | +110.5% | 3,750 | +200.0% | 0.00% | +100.0% |
| Q2 2023 | $3,813 | +17.3% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,250 | +533.5% | 1,250 | +400.0% | 0.00% | – |
| Q4 2022 | $513 | -54.5% | 250 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,128 | +10.3% | 250 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,023 | -7.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,100 | -63.1% | 250 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,978 | -30.6% | 250 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $4,290 | -1.6% | 250 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,360 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 580,902 | $6,919,000 | 40.97% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $51,024,000 | 11.03% |
| MPM BioImpact LLC | 2,388,011 | $28,441,000 | 5.18% |
| RA Capital Management | 4,291,881 | $51,116,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 648,391 | $7,722,000 | 0.85% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 958,125 | $11,411,000 | 0.24% |
| PFM Health Sciences, LP | 400,000 | $4,764,000 | 0.16% |
| Avidity Partners Management LP | 485,000 | $5,776,000 | 0.12% |
| Soleus Capital Management, L.P. | 64,585 | $769,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 213,381 | $2,541,000 | 0.07% |